Professor Jeremy Whelan was appointed as a consultant medical oncologist at UCLH in 1996, retiring from day-to-day clinical service in 2020. He continues as an active advisory member of the London Sarcoma Service (www.londonsarcoma.org), the service he helped build and which is now one of the largest sarcoma services in Europe with particular expertise in the management of bone sarcomas.
Consultant Medical Oncologist
Department of Oncology
UCLH NHS Foundation Trust
250 Euston Road
London NW1 2PG
Professor of Cancer Medicine
Faculty of Medical Sciences
University College London
UCLH is the largest single institution contributing patients to current international clinical trials in osteosarcoma and Ewing’s tumours.
Prof Whelan leads an extensive programme of clinical research in sarcomas. He is a chief investigator of the international randomised study for osteosarcoma, EURAMOS 1, which has completed accrual of over 2000 patients in Europe and the United States.
He has also taken an active role in national cancer policy developments in his areas of expertise. He is currently a member of the National Cancer Research Institute Teenage and Young Adult Clinical Studies Group and NCRI Sarcoma Clinical Studies Group.
Prof Whelan is involved in BRIGHTLIGHT - a large scale group of research projects which look at the quality of the provision of services for people aged 13-24 with cancer.
For an up-to-date list of publications please visit https://iris.ucl.ac.uk/iris/browse/profile?upi=JSWHE70